Extracellular vesicle-mediated amyloid transfer to neural progenitor cells: implications for RAGE and HIV infection

• Published in: Molecular brain 2020-02, Vol.13 (1), p.21-17, Article 21
• Main Authors: András, Ibolya E, Garcia-Contreras, Marta, Yanick, Christopher, Perez, Paola, Sewell, Brice, Durand, Leonardo, Toborek, Michal
• Format: Article
• Language: English
• Subjects: Advanced glycosylation end products; Amyloid beta; Amyloid beta-Peptides - metabolism; Blood-brain barrier; Brain; Brain - pathology; Cell culture; Cell Differentiation; Chemokines - metabolism; Cognition; Endothelial cells; Endothelium; Extracellular vesicles; Extracellular Vesicles - metabolism; Glycosylation; Health aspects; HIV; HIV (Viruses); HIV infection; HIV Infections - metabolism; Human immunodeficiency virus; Humans; Infections; Inflammasomes; Inflammasomes - metabolism; Inflammation Mediators - metabolism; Models, Biological; Neural progenitor cells; Neural stem cells; Neural Stem Cells - metabolism; Neurogenesis; Neurons - metabolism; Pathology; Progenitor cells; Proteins; RAGE; Receptor for Advanced Glycation End Products - metabolism; Scientific equipment and supplies industry; Solubility
• ISSN: 1756-6606; 1756-6606
• DOI: 10.1186/s13041-020-0562-0

Amyloid beta (Aβ) deposition was demonstrated to be elevated in the brains of HIV-infected patients and associated with neurocognitive decline; however, the mechanisms of these processes are poorly understood. The goal of the current study was to address the hypothesis that Aβ can be transferred via extracellular vesicles (ECVs) from brain endothelial cells to neural progenitor cells (NPCs) and that this process can contribute to abnormal NPC differentiation. Mechanistically, we focused on the role of the receptor for advanced glycation end products (RAGE) and activation of the inflammasome in these events. ECVs loaded with Aβ (Aβ-ECVs) were readily taken up by NPCs and Aβ partly colocalized with the inflammasome markers ASC and NLRP3 in the nuclei of the recipient NPCs. This colocalization was affected by HIV and RAGE inhibition by a high-affinity specific inhibitor FPS-ZM1. Blocking RAGE resulted also in an increase in ECV number produced by brain endothelial cells, decreased Aβ content in ECVs, and diminished Aβ-ECVs transfer to NPC nuclei. Interestingly, both Aβ-ECVs and RAGE inhibition altered NPC differentiation. Overall, these data indicate that RAGE inhibition affects brain endothelial ECV release and Aβ-ECVs transfer to NPCs. These events may modulate ECV-mediated amyloid pathology in the HIV-infected brain and contribute to the development of HIV-associated neurocognitive disorders.